Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: A systematic review and meta-analysis

Stroke

Volumn 36, Issue 12, 2005, Pages 2748-2755

  Touzé, Emmanuel ^a   Varenne, Olivier ^b   Chatellier, Gilles ^c   Peyrard, Séverine ^c   Rothwell, Peter M ^d   Mas, Jean Louis ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Hôpital Cochin ^*  (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Atherosclerosis; Cerebrovascular accident; Coronary disease; Meta analysis; Myocardial infarction; Prognosis; Risk factors

Indexed keywords

CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COHORT ANALYSIS; CORONARY ARTERY DISEASE; FOLLOW UP; HEART INFARCTION; HUMAN; META ANALYSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; TRANSIENT ISCHEMIC ATTACK; VASCULAR DISEASE; AGED; CAUSE OF DEATH; COMORBIDITY; FEMALE; INCIDENCE; MALE; REGRESSION ANALYSIS; RISK ASSESSMENT; SURVIVAL;

AGED; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; ISCHEMIC ATTACK, TRANSIENT; MALE; MYOCARDIAL INFARCTION; REGRESSION ANALYSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 33644671211     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000190118.02275.33     Document Type: Review

References (58)

1. Pasternak RC, Criqui MH, Benjamin EJ, Fowkes FG, Isselbacher EM, McCullough PA, Wolf PA, Zheng ZJ. Atherosclerotic Vascular Disease Conference: Writing Group I: Epidemiology. Circulation. 2004;109:2605-2612.
2. Adams RJ, Chimowitz MI, Alpert JS, Awad IA, Cerqueria MD, Fayad P, Taubert KA. Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Circulation. 2003;108:1278-1290.
3. Dennis MS, Burn JPS, Sandercock PAG, Bamford JM, Wade DT, Warlow CP. Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project. Stroke. 1993;24:786-800.
4. Ariesen MJ, Algra A, Warlow CP, Rothwell PM; Cerebrovascular Cohort Studies Collaboration. Prognostic factors of primary intracerebral hemorrhage risk in patients after an episode of cerebral ischemia. J Neurol Neurosurg Psychiatry. In press.
5. Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med. 2002;21:1559-1573.
6. van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med. 2002;21:589-624.
7. Thompson SG, Sharp SJ. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med. 1999;18:2693-2708.
8. UK-TIA Study Group. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry. 1991;54:1044-1054.
9. Dennis M, Bamford J, Sandercock P, Warlow C. Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project. Stroke. 1990;21:848-853.
10. Gates PC, Eliasziw M, Algra A, Barnett HJM, Gunton RW; North American Symptomatic Carotid Endarterectomy Trial Group. Identifying patients with symptomatic carotid artery disease at high and low risk of severe myocardial infarction and cardiac death. Stroke. 2002;33:2413-2416.
11. Rothwell PM, Villagra R, Gibson R, Donders RC, Warlow CP. Evidence of a chronic systemic cause of instability of atherosclerotic plaques. Lancet. 2000;355:19-24.
12. Bousser MG, Eschwege E, Haguenau M, Lefaucconnier JM, Thibult N, Touboul D, Touboul PJ. "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of atherothrombotic cerebral ischemia. Stroke. 1983;14:5-14.
13. Sorensen PS, Pedersen H, Marquardsen J, Petersson H, Heltberg A, Simonsen N, Munck O, Andersen LA. Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks. A Danish cooperative study. Stroke. 1983;14:15-22.
14. Persantine Aspirin Trial in Cerebral Ischemia. Part II: endpoint results. The American-Canadian Cooperative Study Group. Stroke. 1985;16:406-415.
15. The EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomised trial. N Engl J Med. 1985;313:1191-1200.
16. Eriksson SE. Enteric-coated acetylsalicylic acid plus dipyridamole compared with anticoagulants in the prevention of ischemic events in patients with transient ischemic attacks. Acta Neurol Scand. 1985;71:485-493.
17. Gent M, Blakely JA, Hachinski V, Roberts RS, Barnett HJ, Bayer NH, Carruthers SG, Collins SM, Gawel MG, Giroux-Klimek M. A secondary prevention, randomized trial of suloctidil in patients with a recent history of thromboembolic stroke. Stroke. 1985;16:416-424.
18. High-dose acetylsalicylic acid after cerebral infarction. A Swedish Cooperative Study. Stroke. 1987;18:325-334.
19. Boysen G, Sorensen PS, Juhler M, Andersen AR, Boas J, Olsen JS, Joensen P. Danish very-low-dose aspirin after carotid endarterectomy trial. Stroke. 1988;19:1211-1215.
20. Hass WK, Easton JD, Adams HP Jr, Pryse-Phillips W, Molony BA, Anderson S, Kamm B. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. N Engl J Med. 1989;321:501-507.
21. Gent M, Blakely JA, Easton JD, Ellis DJ, Hachinski VC, Harbison JW, Panak E, Roberts RS, Sicurella J, Turpie AG. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet. 1989;1:1215-1220.
22. ESPS Group. European Stroke Prevention Study. Stroke. 1990;21:1122-1130.
23. The SALT Collaborative Group. Swedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet. 1991;338:1345-1349.
24. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-1339.
25. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996;143:1-13.
26. Ito E, Takahashi A, Yamamoto H, Kuzuhara S, Uchiyama S, Nakajima M. Ticlopidine alone versus ticlopidine plus aspirin for preventing recurrent stroke. Intern Med. 2003;42:793-799.
27. Matias-Guiu J, Ferro JM, Alvarez-Sabin J, Torres F, Jimenez MD, Lago A, Melo T, Tong DC. Comparison of Triflusal and Aspirin for Prevention of Vascular Events in Patients After Cerebral Infarction: the TACIP Study: a randomized, double-blind, multicenter trial. Can aspirin ever be surpassed for stroke prevention? Stroke. 2003;34:840-848.
28. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:331-337.
29. Heart Protection Study Collaborative Group. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions. Lancet. 2004;363:757-767.
30. Culebras A, Rotta-Escalante R, Vila J, Dominguez R, Abiusi G, Famulari A, Rey R, Bauso-Tosselli L, Gori H, Ferrari J, Reich E. Triflusal vs aspirin for prevention of cerebral infarction: a randomized stroke study. Neurology. 2004;62:1073-1080.
31. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang CH, Stampfer M. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. J Am Med Assoc. 2004;291:565-575.
32. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305-1316.
33. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033-1041.
34. Howard G, Evans GW, Murros KE, Toole JF, Lefkowitz D, Truscott BL. Cause specific mortality following cerebral infarction. J Clin Epidemiol. 1989;42:45-51.
35. Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Burvill PW, Anderson CS, Stewart-Wynne EG. Five-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study. Stroke. 2000;31:2080-2086.
36. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989. Neurology. 1998;50:208-216.
37. Loor HI, Groenier KH, Limburg M, Schuling J, Meyboom-de Jong B. Risks and causes of death in a community-based stroke population: 1 month and 3 years after stroke. Neuroepidemiology. 1999;18:75-84.
38. Hartmann A, Rundek T, Mast H, Paik MC, Boden-Albala B, Mohr JP, Sacco RL. Mortality and causes of death after first ischemic stroke. The Northern Manhattan Stroke Study. Neurology. 2001;57:2000-2005.
39. Terent A. Cerebrovascular mortality 10 years after stroke: a population-based study. Stroke. 2004;35:E343-E345.
40. Olsson JE, Brechter C, Backlund H, Krook H, Muller R, Nitelius E, Olsson O, Tornberg A. Anticoagulant vs anti-platelet therapy as prophylactic against cerebral infarction in transient ischemic attacks. Stroke. 1980;11:4-9.
41. Simonsen N, Christiansen HD, Heltberg A, Marquardsen J, Pedersen HE, Sorensen PS. Long-term prognosis after transient ischemic attacks. Acta Neurol Scand. 1981;63:156-168.
42. Muuronen A, Kaste M. Outcome of 314 patients with transient ischemic attacks. Stroke. 1982;13:24-31.
43. Carolei A, Candelise L, Fiorelli M, Francucci BM, Motolese M, Fieschi C. Long-term prognosis of transient ischemic attacks and reversible ischemic neurologic deficits: a hospital-based study. Cerebrovasc Dis. 1992;2:272.
44. Falke P, Lindgärde F, Stavenow L. Prognostic indicators for mortality in transient ischemic attack and minor stroke. Acta Neurol Scand. 1994;90:78-82.
45. Salgado AV, Ferro JM, Gouveia-Oliveira A. Long-term prognosis of first-ever lacunar strokes. A hospital-based study. Stroke. 1996;27:661-666.
46. Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 1999; 100:1481-1492.
47. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and Other Societies on Coronary Prevention. Eur Heart J. 1998;19:1434-1503.
48. Hertzer NR, Young JR, Beven EG, Graor RA, O'Hara PJ, Ruschhaupt WF, deWolfe VG, Maljovec LC. Coronary angiography in 506 patients with extracranial cerebrovascular disease. Arch Intern Med. 1985;145:849-852.
49. D'Agostino RB, Russell MW, Huse DM, Ellison RC, Silbershatz H, Wilson PW, Hartz SC. Primary and subsequent coronary risk appraisal: new results from the Framingham Study. Am Heart J. 2000;139:272-281.
50. Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S, Glahn J, Brandt T, Hacke W, Diener HC. Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German Stroke Data Bank. Stroke. 2001;32:2559-2566.
51. Mathur KS, Kashyap SK, Kumar V. Correlation of the extent and severity of atherosclerosis in the coronary and cerebral arteries. Circulation. 1963;27:929-934.
52. Solberg LA, McGarry PA, Moossy J, Strong JP, Tejada C, Löken AC. Severity of atherosclerosis in cerebral arteries, coronary arteries, and aortas. Ann N Y Acad Sci. 1968;149:956-973.
53. Joakimsen O, Bonaa KH, Mathiesen EB, Stensland-Bugge E, Arnesen E. Prediction of mortality by ultrasound screening of a general population for carotid stenosis: the Tromso Study. Stroke. 2000;31:1871-1876.
54. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU. Epidemiology of ischemic stroke subtypes according to TOAST criteria. Incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke. 2001;32:2735-2740.
55. Longstreth WT Jr, Bernick C, Fitzpatrick A, Cushman M, Knepper L, Lima J, Furberg CD. Frequency and predictors of stroke death in 5888 participants in the Cardiovascular Health Study. Neurology. 2001;56:368-375.
56. Thompson SG, Higgins JP. Can meta-analysis help target interventions at individuals most likely to benefit? Lancet. 2005;365:341-346.
57. Holloway RG, Benesch C, Rush SR. Stroke prevention. Narrowing the evidence-practice gap. Neurology. 2000;54:1899-1906.
58. Eagle KA, Guyton RA, Davidoff R, Ewy GA, Fonger J, Gardner TJ, Gott JP, Herrmann HC, Marlow RA, Nugent W, O'Connor GT, Orszulak TA, Rieselbach RE, Winters WL, Yusuf S, Gibbons RJ, Alpert JS, Garson A Jr, Gregoratos G, Russell RO, Ryan TJ, Smith SC Jr. ACC/AHA guidelines for coronary artery bypass graft surgery: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1991 guidelines for coronary artery bypass graft surgery). Circulation. 1999;100:1464-1480.